Generics 21

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Olaparib manufacturers

21 products found

Filters

21 products found

olaparib

Tablets, film coated 100 mg, 150 mg

Dossier type
US CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 6 days

olaparib

Tablets, film coated 100 mg, 150 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA, Saudi Arabia, South Korea, Libya, Turkey, LY, SA, KR, TR
Comments
Reference product: Lynparza. Patent: EU - 09/2029 (Pediatric exclusivity), US - 09/2027 (Patent term extension)
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 42 days

olaparib

Tablets, film coated 100 mg, 150 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
BE studies: Not required (Pilot BE), Sep 2026 (Pivotal BE)
Manufacturer #673

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, CIS, and Oceania for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include neurology, cardiology, and infectiology. The company's production lines are EU GMP-compliant. The company possesses branches in 10+ countries in Europe and CIS.

Manufacturer usually replies in 35 days

Want to see all 21 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible